
Cancer costs are steadily rising, presenting a significant financial challenge for U.S. employers and unions. With the treatment expenses nearing 3% of the national GDP and a notable increase in incidence among those under 50, businesses are under pressure to find sustainable solutions. In response, many are turning their focus from treatment to prevention, emphasizing the importance of early detection.









